nearly significantp = 0.067
A nearly significant result was also observed for CD147 ( p = 0.067, Figure 2 D), nevertheless, co-expression of CD147 along with MCT4 (Figure 2 F), but not MCT1 (Figure 2 E), showed a significant association with poorer overall survival, with patients with double MCT4/CD147 positive tumors showing a median overall survival of 19.5 months versus 34.6 months in the remaining group ( p = 0.005).